TY - JOUR
T1 - Creative approaches for assessing long-term outcomes in children
AU - Wu, Ann Chen
AU - Graif, Corina
AU - Mitchell, Shannon Gwin
AU - Meurer, John
AU - Mandl, Kenneth D.
N1 - Funding Information:
FUNDING: Dr. Wu received funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; R01 HD090019-01 and R01 HD085993-01); Dr Graif received funding from NICHD (K01-HD093863 and P2C-HD041025); Dr Meurer received funding from the Medical College of Wisconsin, Advancing a Healthier Wisconsin Endowment, Research and Education Program Fund; Dr. Mandl received funding from the National Center for Advancing Translational Sciences/NIH (U01TR002623). Funded by the National Institutes of Health (NIH).
Publisher Copyright:
Copyright © 2021 by the American Academy of Pediatrics
PY - 2021/7/1
Y1 - 2021/7/1
N2 - Advances in new technologies, when incorporated into routine health screening, have tremendous promise to benefit children. The number of health screening tests, many of which have been developed with machine learning or genomics, has exploded. To assess efficacy of health screening, ideally, randomized trials of screening in youth would be conducted; however, these can take years to conduct and may not be feasible. Thus, innovative methods to evaluate the long-term outcomes of screening are needed to help clinicians and policymakers make informed decisions. These methods include using longitudinal and linked-data systems to evaluate screening in clinical and community settings, school data, simulation modeling approaches, and methods that take advantage of data available in the digital and genomic age. Future research is needed to evaluate how longitudinal and linked-data systems drawing on community and clinical settings can enable robust evaluations of the effects of screening on changes in health status. Additionally, future studies are needed to benchmark participating individuals and communities against similar counterparts and to link big data with natural experiments related to variation in screening policies. These novel approaches have great potential for identifying and addressing differences in access to screening and effectiveness of screening across population groups and communities.
AB - Advances in new technologies, when incorporated into routine health screening, have tremendous promise to benefit children. The number of health screening tests, many of which have been developed with machine learning or genomics, has exploded. To assess efficacy of health screening, ideally, randomized trials of screening in youth would be conducted; however, these can take years to conduct and may not be feasible. Thus, innovative methods to evaluate the long-term outcomes of screening are needed to help clinicians and policymakers make informed decisions. These methods include using longitudinal and linked-data systems to evaluate screening in clinical and community settings, school data, simulation modeling approaches, and methods that take advantage of data available in the digital and genomic age. Future research is needed to evaluate how longitudinal and linked-data systems drawing on community and clinical settings can enable robust evaluations of the effects of screening on changes in health status. Additionally, future studies are needed to benchmark participating individuals and communities against similar counterparts and to link big data with natural experiments related to variation in screening policies. These novel approaches have great potential for identifying and addressing differences in access to screening and effectiveness of screening across population groups and communities.
UR - http://www.scopus.com/inward/record.url?scp=85109738819&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109738819&partnerID=8YFLogxK
U2 - 10.1542/peds.2021-050693F
DO - 10.1542/peds.2021-050693F
M3 - Article
C2 - 34210844
AN - SCOPUS:85109738819
SN - 0031-4005
VL - 148
SP - S25-S32
JO - Pediatrics
JF - Pediatrics
ER -